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that is an important part of the teaching content for pharma-
cists, but this knowledge is not always taught to other medical
health professionals, such as doctors and dentists. Doctors and
dentists mainly have knowledge about modern pharmacology
and prescribe conventional drugs within the contexts of phar-
macology and toxicology (Saeidnia and Abdollahi, 2013;
Ghanemi, 2014c). However, because doctors and dentists must
manage the health status of their patients and prescribe drugs,
they should consider factors that could inﬂuence the effects of
prescription drugs, including natural compounds and the
active ingredients these compounds may contain. By natural
compounds, we refer to products used as traditional, herbal,
or natural therapies, as well as diet products. In fact, the active
ingredients of natural compounds may inﬂuence the physiolog-
ical and pathological status of patients and may interact with
therapies when they are taken together.
Furthermore, a variety of drugs have been developed from
natural products, indicating that compounds derived from nat-
ural products can have strong biological and pharmacological
activities (Patwardhan, 2005). Indeed, different pharmacologi-
cal properties have been linked to natural compounds and
have been proposed as potential candidates for the develop-
ment of therapeutic agents (Ghanemi and Boubertakh, 2014;
Ghanemi, 2013, 2014b,d; Boubertakh et al., 2013). Therefore,
as clinicians who prescribe medicines, doctors and dentists
should be aware of these factors to select the best therapeutic
approaches. In addition, they must guide their patients to
avoid, or at least minimize, the interactions between natural
compounds and prescribed drugs. Natural compounds may
inﬂuence drug effects not only by interacting with a drug but
also by modifying a drug’s targets, such as membrane recep-
tors (Ghanemi et al., 2013).
In addition, even in patients who are not prescribed ther-
apy, doctors and dentists should explain the risks related to
the use of natural products by clarifying that natural productsare not guaranteed to be safe and that foods and beverages can
have pharmacological or toxicological effects. Thus, patients
who consume natural compounds should pay attention to
factors such as the timing, quantity, and frequency that they
take these products with respect to prescribed drugs and with
respect to their physiological or pathological status. As a
related point, natural compounds can also inﬂuence the results
of biomedical analyses on which prescriptions may be based
because the chemicals in natural compounds may interact with
cells or with laboratory reagents and lead to false results
(Ghanemi 2014a,e).
In conclusion, the study of the pharmacological and toxico-
logical properties of natural compounds is no less important
for doctors (Simaan, 2009) and dentists than it is for pharma-
cists. More attention should be paid to topics regarding
natural compounds within the faculty of medicine.
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